Roland L Hodges

Title: Innovations of Roland L. Hodges

Introduction

Roland L. Hodges is a notable inventor based in Indianapolis, IN (US). He has made significant contributions to the field of biotechnology, particularly in the area of recombinant DNA technology. With a total of 2 patents, his work has advanced the understanding and application of genetic engineering.

Latest Patents

Hodges' latest patents include groundbreaking inventions in recombinant DNA compounds. One of his patents focuses on DNA compounds that encode ACV synthetase activity of Cephalosporium acremonium. This invention provides DNA compounds that can be utilized to construct recombinant DNA expression vectors for various host cells, including Penicillium, Cephalosporium, and Aspergillus. Another significant patent involves isolated DNA compounds and recombinant DNA cloning and expression vectors that encode PNB esterase from Bacillus subtilis. This invention also details host cells transformed with these vectors and a method for producing the PNB esterase through recombinant DNA techniques.

Career Highlights

Hodges is currently associated with Eli Lilly and Company, where he continues to contribute to innovative research and development. His work at Eli Lilly has positioned him as a key player in the biotechnology sector, focusing on the development of novel therapeutic solutions.

Collaborations

Throughout his career, Hodges has collaborated with esteemed colleagues, including Cathleen Alice Cantwell and Stephen W. Queener. These collaborations have fostered a productive environment for innovation and have led to advancements in their respective fields.

Conclusion

Roland L. Hodges exemplifies the spirit of innovation in biotechnology through his patents and contributions to recombinant DNA technology. His work continues to influence the industry and pave the way for future advancements.